HS-/KN-Code 30021010 ist für die EUDR-Vorbereitung außerhalb des Geltungsbereichs.
Antisera(2012-2016);Antisera(2002-2011);Antisera(1988-2001) Die indexierte Scope-Engine liefert für diesen Code das Ergebnis Out of scope. No Annex I scope match was found for this indexed CN code.
Warum diese Referenzseite diese Antwort gibt.
- Code-Beschreibung
- Antisera(2012-2016);Antisera(2002-2011);Antisera(1988-2001)
- Anhang-I-Grundlage
- Kein direkter Anhang-I-Eintrag
- Quellengrundlage
- Regulation (EU) 2023/1115 Annex I and CN 2026 index
Übergeordnete, untergeordnete und benachbarte Zeilen.
Die Bibliotheksansicht dient der Referenznavigation. Nutzen Sie die HS-Code-Prüfung, wenn Sie einen weiteren Code aktiv prüfen möchten.
30pharmazeutische erzeugnisseout3002human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excl. yeasts) and similar productsout300210antisera and other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processesout30021091haemoglobin, blood globulins and serum globulins(2012-2016);haemoglobin, blood globulins and serum globulins(2002-2011);haemoglobin, blood globulins and serum globulins(1988-2001)out30021095blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes, of human blood (excl. antisera, haemoglobin, blood globulins and serum globulins)(2012-2012);blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes, of human blood (excl. antisera, haemoglobin, blood globulins and serum globulins)(2002-2011);blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes, of human blood (excl. antisera, haemoglobin, blood globulins and serum globulins)(1988-2001)out30021098blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes (excl. antisera, haemoglobin, blood globulins and serum globulins)out30021099blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes, of animal blood (excl. antisera, haemoglobin, blood globulins and serum globulins)(2012-2012);blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes, of animal blood (excl. antisera, haemoglobin, blood globulins and serum globulins)(2002-2011);blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes, of animal blood (excl. antisera, haemoglobin, blood globulins and serum globulins)(1988-2001)out
Was das für die Vorbereitung bedeutet.
Diese Zeile ist im aktuellen Geltungsbereichs-Ergebnis kein direkter Auslöser für die Nachweiserhebung.
Regulation (EU) 2023/1115 Annex I — relevant productsabgerufen am 2026-08-06Commission Delegated Regulation (EU) 2026/2102 amending Annex I to Regulation (EU) 2023/1115abgerufen am 2026-09-24Eurostat Comext Combined Nomenclature codelist (CXT_NC v11.0)abgerufen am 2026-08-06Eurostat Comext partner country codelist (CXT_FREE_ISO)abgerufen am 2026-08-06Eurostat Comext DS-045409 — EU trade since 1988 by HS2-4-6 and CN8abgerufen am 2026-08-06Commission Implementing Regulation (EU) 2025/1093 — country benchmarkingabgerufen am 2026-08-06Regulation (EU) 2025/2650 amending Regulation (EU) 2023/1115 as regards certain obligations of operators and tradersabgerufen am 2025-12-26Commission Implementing Regulation (EU) 2026/1565 amending Implementing Regulation (EU) 2024/3084 (EUDR information system)abgerufen am 2026-08-08